RxDoctor Payments Data

Emil Anthony Say, MD

Retina Specialist · Charleston, SCNPI 1659685063

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for retina specialist clinicians in SC, where the typical reported total is $2,421.

$1,212in general payments, 2019–2025

Across 26 payments — averaging $46.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$267
  • Astellas Pharma US Inc$176
  • AbbVie$136
  • Axogen$121
  • Omeros Corporation$120
  • Regeneron Healthcare Solutions, Inc.$114
  • plus $278 from 5 others

What the payments were for

  • Food & beverage$1,212100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,212 in reported general payments places this provider in the 30th percentile of 20 retina specialist providers in South Carolina.

See all retina specialist providers in South Carolina

Medicare billing

Part B allowed, 2024
$929,706
Medicare patients
787
Services billed
18,195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate119$6,140
Alphagan PBrimonidine Tartrate12$4,697
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat56$895
Brimonidine Tartrate28$550
Ofloxacin39$447
Ketorolac Tromethamine13$373
Timolol Maleate35$329
Latanoprost42$307
Dorzolamide Hcl22$288
Prednisone15$98

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieAlphagan P$136$4,69712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 20 retina specialist providers in South Carolina.

Other retina specialist in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →